Evidence of the effectiveness and safety of first-line smoking cessation pharmacotherapy

Evangelia Liakoni, Neal L. Benowitz

Source: Eur Respir Monogr 2021; 90: 97-117
Disease area: Airway diseases

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Evangelia Liakoni, Neal L. Benowitz. Evidence of the effectiveness and safety of first-line smoking cessation pharmacotherapy. Eur Respir Monogr 2021; 90: 97-117

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness and cost-effectiveness of smoking cessation interventions
Source: International Congress 2015 – New advances in smoking cessation interventions
Year: 2015



Efficacy of nicotineless non-pharmacologic alternative tool for smoking cessation program using varenicline
Source: Annual Congress 2012 - Tobacco cessation
Year: 2012

Efficacy of bupropion therapy in smoking cessation
Source: Eur Respir J 2004; 24: Suppl. 48, 153s
Year: 2004

Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD
Source: Annual Congress 2010 - Smoking related disorders and smoking cessation
Year: 2010

Comparison of efficacy of varenicline and nortriptyline– Short-term smoking cessation in outpatient setting
Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products
Year: 2016


Effectiveness of varenicline treatment in a smoking cessation clinic
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009


The efficacy of motivational aupport in cigarette cessation treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 387s
Year: 2005

Is NRT in combination with other drugs more effective than NRT alone in smoking cessation?
Source: ISSN=ISSN 1810-6838, ISBN=, page=246
Year: 2005

Cost-effectiveness of 5 smoking cessation interventions
Source: Eur Respir J 2004; 24: Suppl. 48, 463s
Year: 2004

Smoking cessation in COPD, modelling the cost effectiveness of minimal counseling or intensive counseling plus bupropion
Source: Eur Respir J 2004; 24: Suppl. 48, 463s
Year: 2004

Evaluation of prolonged bupropion treatment as an aid in smoking cessation
Source: Eur Respir J 2002; 20: Suppl. 38, 611s
Year: 2002

Efficacy and safety of bupropion for the treatment of smoking cessation in patients with chronic bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 503s
Year: 2004

Effectiveness of treatment with bupropion HCL, NRTs and combination in smoking cessation
Source: Eur Respir J 2004; 24: Suppl. 48, 156s
Year: 2004

Cost effectiveness of retreatment with varenicline compared to other commonly used smoking cessation interventions
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015



Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008


Effectiveness of a personalized smoking cessation counseling program in patients with oral cancer: preliminary results
Source: International Congress 2017 – Smoking cessation
Year: 2017


Bupropion treatment and cognitive behavioural therapy in a smoking cessation program
Source: Eur Respir J 2001; 18: Suppl. 33, 12s
Year: 2001

Cytisine is an effective smoking cessation medication: more evidence now than ever before
Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Year: 2017

The cost-effectiveness of antidepressants for smoking cessation in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 801s
Year: 2006

Medical treatment effectiveness in smoking cessation
Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Year: 2017